Your browser doesn't support javascript.
loading
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer, Emanuel; D'Haese, David; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; Chovanec, Michal; Winquist, Eric; Grimison, Peter; Feldman, Darren R; Terbuch, Angelika; Hentrich, Marcus; Bokemeyer, Carsten; Negaard, Helene; Fankhauser, Christian; Shamash, Jonathan; Vaughn, David J; Sternberg, Cora N; Heidenreich, Axel; Collette, Laurence; Gillessen, Silke; Beyer, Jörg.
Affiliation
  • Bührer E; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • D'Haese D; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Daugaard G; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • de Wit R; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Albany C; Horizon Oncology Research, 1345 Unity PI Ste 345, Lafayette, IN, United States of America.
  • Tryakin A; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation.
  • Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Stahl O; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Gietema JA; University Medical Centre Groningen, Groningen, the Netherlands.
  • De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy and the Italian Germ Cell Cancer Group (IGG), Italy.
  • Cafferty FH; Medical Research Council Clinical Trials Unit, University College London (UCL), London, United Kingdom; Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom.
  • Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Tandstad T; The Cancer Clinic, St Olavs University Hospital and Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway.
  • Huddart RA; Institute of Cancer Research, Sutton, United Kingdom.
  • Necchi A; Vita-Salute San Raffaele University, Milan, Italy; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.
  • Garcia-Del-Muro X; Catalan Institute of Oncology, IDIBELL Institute of Research, University of Barcelona, Barcelona, Spain.
  • Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
  • Lorch A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Department of Urology, University Hospital Dusseldorf, Dusseldorf, Germany.
  • Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia; Cancer Research Institute, Biomedical Center, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Winquist E; Division of Medical Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Grimison P; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia.
  • Feldman DR; Memorial Sloan Kettering Cancer Centre, New York, NY, United States of America; Weill Medical College of Cornell University, New York, NY, United States of America.
  • Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany.
  • Bokemeyer C; Department of Oncology, Hematology and BMT with Section Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Negaard H; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Fankhauser C; University of Zurich, Zurich, Switzerland.
  • Shamash J; St Bartholomew's Hospital, London, United Kingdom.
  • Vaughn DJ; University of Pennsylvania, Philadelphia, PA, United States of America.
  • Sternberg CN; Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Heidenreich A; Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany; Department of Urology, Medical University Vienna, Austria.
  • Collette L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Gillessen S; Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona, Switzerland; Universita della Svizzera Italiana (USI), Lugano, Switzerland.
  • Beyer J; University Department of Medical Oncology, Inselspital, University Hospital, University of Bern, Bern, Switzerland. Electronic address: joerg.beyer@insel.ch.
Eur J Cancer ; 202: 114042, 2024 May.
Article in En | MEDLINE | ID: mdl-38564927
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teratoma / Testicular Neoplasms / Seminoma / Neoplasms, Germ Cell and Embryonal Limits: Humans / Male Language: En Journal: Eur J Cancer Year: 2024 Document type: Article Affiliation country: Bélgica Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teratoma / Testicular Neoplasms / Seminoma / Neoplasms, Germ Cell and Embryonal Limits: Humans / Male Language: En Journal: Eur J Cancer Year: 2024 Document type: Article Affiliation country: Bélgica Country of publication: Reino Unido